服務(wù)承諾：工作時(shí)間內(nèi)提供免費(fèi)的技術(shù)咨詢和指導(dǎo) 。我公司的技術(shù)人員都經(jīng)過專業(yè)培訓(xùn)的，將為您提供滿意的產(chǎn)品和真誠的服務(wù)。
N-乙基-N-(2-羥基-3-磺丙基)-3-甲基本胺鈉鹽 號(hào)：82692-93-1  
英文名稱：TOOS sodium salt；Sodium 3-(N-ethyl-3-methylanilino)-2-hydroxypropanesulfonate；3-(N-Ethyl-3-methylanilino)-2-hydroxypropanesulfonic acid sodium salt   
其他名稱：N-乙基-N-(2-羥基-3-磺丙基)間甲苯胺鈉鹽   
號(hào)：82692-93-1   
C12H18NNaO4S=295.33   
級(jí)別：試劑級(jí)   
含量：≥98%   
性狀(以下信息僅供參考)：白色結(jié)晶粉末。溶于水   
用途：本品僅供科研，不得用于其它用途。(以下用途僅供參考)用于酶光度法測定過氧化輕。   
保存：RT，避光。保質(zhì)期5年  客戶根據(jù)N-乙基-N-(2-羥基-3-磺丙基)-3-甲基本胺鈉鹽 號(hào)：82692-93-1性質(zhì)、化學(xué)式、分子式、結(jié)構(gòu)式、比重、密度、號(hào)、沸點(diǎn)、熔點(diǎn)、水溶性、MSDS、用途、作用、規(guī)格包裝、性狀、注意事項(xiàng)、英文名、別稱、純度、級(jí)別等情況，本產(chǎn)品化學(xué)性質(zhì)穩(wěn)定，運(yùn)輸條件不苛刻，一般儲(chǔ)存在陰涼，干燥，通風(fēng)良好的地方，遠(yuǎn)離不相容的物質(zhì)。保持容器密閉。
試劑品牌：TCI、sigma、Alfa、Avocado、Aldrich、ACROS、Fluka、ICN（MP）等
包裝：1kg、100g、10g、250g、25g、500g、50g、5g等包裝
級(jí)別：GR級(jí)別、AR級(jí)別、CP級(jí)別、L.P.級(jí)別等
公司提供的N-乙基-N-(2-羥基-3-磺丙基)-3-甲基本胺鈉鹽 號(hào)：82692-93-1*，貨源充足。嚴(yán)格的生產(chǎn)質(zhì)量控制體系，包括：優(yōu)級(jí)純，分析純，化學(xué)純，試劑級(jí)，基準(zhǔn)試劑，實(shí)驗(yàn)純，教學(xué)試劑，高純?cè)噭V純，光譜純，電子純。各種包裝規(guī)格，并可提供包裝定制，咨詢訂購。

購買須知：
【價(jià)格方面】   
    每個(gè)時(shí)期原料的價(jià)格都會(huì)波動(dòng)，產(chǎn)品的價(jià)格會(huì)有所升降，以上報(bào)價(jià)僅為參考報(bào)價(jià)！咨詢選購！

 【付款方式】 
    現(xiàn)金，支付寶，銀行轉(zhuǎn)帳，匯款，支票，本票；
    請(qǐng)將款項(xiàng)匯至我司公司賬戶（開票的）或者老板的私人賬戶上面，接受支付寶付款； 
    我司收到款項(xiàng)后會(huì)根據(jù)客戶的相關(guān)要求盡快安排發(fā)貨！

    【發(fā)貨時(shí)間】 
     物流基本上在下午2點(diǎn)之前提交確認(rèn)的訂單，都將盡力安排當(dāng)天發(fā)貨； 
    如果訂單產(chǎn)品需要拆分及其他特殊情況的要求，則可能會(huì)有一定的延時(shí)。

    【配送方式】 
    確定的訂單后，小貨我司將通過順豐、韻達(dá)等快遞送達(dá)； 
    大量貨物會(huì)更具情況以德邦、遠(yuǎn)成，普華，中鐵等物流的運(yùn)輸方式發(fā)貨。

    【其他服務(wù)】 
    如您對(duì)產(chǎn)品特性及技術(shù)指標(biāo)有特殊要求，我公司可以提供質(zhì)檢單和相關(guān)產(chǎn)品的資料和文件； 
    如果對(duì)產(chǎn)品的包裝或者分裝的有要求的話，也請(qǐng)及時(shí)通知我方，我方好根據(jù)要求盡量滿足您的所需求。

    【服務(wù)宗旨】 
    竭誠提供優(yōu)質(zhì)產(chǎn)品，售后服務(wù)客戶滿意度100％
through an intramolecular interaction between the SH2 domain and the carboxyl terminus when tyrosine 529 is phosphorylated by Csk. This conformation blocks phosphorylation of tyrosine 418 at the catalytic domain, thereby preventing Src activation. When tyrosine 529 is dephosphorylated, tyrosine 418 can be maximally phosphorylated and Src becomes active. Src is a proto oncogene that may play a role in the regulation of embryonic development and cell growth. Mutations in this gene could be involved in the malignant progression of colon cancer. Immunogen: Synthetic peptide (Human) derived from the region of Src that contains tyrosine 529, based on the human sequence. The sequence is conserved in mouse (tyrosine 534), chicken (tyrosine 527) and frog (tyrosine 525).
Function : Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN). When cells adhere via focal adhesions to the extra-cellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1. Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation. Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of ADRBK1, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376'.
Subunit : Interacts with DDEF1/ASAP1; via the SH3 domain. Interacts with CCPG1. Identified in a complex containing FGFR4, NCAM1, CDH2, PLCG1, FRS2, SRC, SHC1, GAP43 and CTTN (By similarity). Interacts with ERBB2, STAT1 and PNN (By similarity). Interacts with CDCP1, PELP1, TGFB1I1 and TOM1L2. Interacts with the cytoplasmic domain of MUC1, phosphorylates it and increases binding of MUC1 with beta-catenin. Interacts with RALGPS1; via the SH3 domain. Interacts with HEV ORF3 protein; via the SH3 domain. Interacts with CAV2 (tyrosine phosphorylated form). Interacts (via the SH3 domain and the protein kinase domain) with ARRB1; the interaction is independent of the phosphorylation state of SRC C-terminus. Interacts with ARRB1 and ARRB2. Interacts with SRCIN1. Interacts with NDFIP2 and more weakly with NDFIP1. Interacts with PIK3CA and/or PIK3C2B, PTK2/FAK1 and ESR1 (dimethylated on arginine). Interacts with FASLG. Interacts (via SH2 domain) with the 'Tyr-402' phosphorylated form of PTK2B/PYK2. Interacts (via SH2 domain) with FLT3 (tyrosine phosphorylated). Interacts with PDGFRA (tyrosine phosphorylated). Interacts with CSF1R (By similarity). Interacts (via SH2 and SH3 domain) with TNK2. Interacts (via protein kinase domin) with the tyrosine phosphorylated form of RUNX3 (via runt domain). Interacts with TRAF3 (via RING-type zinc finger domain). Interacts with DDX58, MAVS and TBK1. Interacts (via SH2 domain) with GNB2L1/RACK1; the interaction is enhanced by tyrosine phosphorylation of GNB2L1 and inhibits SRC activity. Interacts with EPHB1; activates the MAPK/ERK cascade to regulate cell migration. Interacts with FCAMR. Interacts (via SH2 domain) with the 'Tyr-9' phosphorylated form of PDPK1.
Subcellular Location : Cell membrane. Mitochondrion inner membrane. Nucleus. Cytoplasm, cytoskeleton. Note=Localizes to focal adhesion sites following integrin engagement. Localization to focal adhesion sites requires myristoylation and the SH3 domain.
Tissue Specificity : Expressed ubiquitously. Plaets, neurons and osteoclasts express 5-fold to 200-fold higher levels than most other tissues.
Post-translational modifications : Myristoylated at Gly-2, and this is essential for targeting to membranes.
Dephosphorylated at Tyr-530 by PTPRJ (By similarity). Phosphorylated on Tyr-530 by c-Src kinase (CSK). The phosphorylated